GEODE CAPITAL MANAGEMENT, LLC - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 15 filers reported holding AKARI THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$5,141
-6.4%
30,2640.0%0.00%
Q1 2023$5,495
+39150.0%
30,2640.0%0.00%
Q4 2022$14
-99.9%
30,2640.0%0.00%
Q3 2022$19,000
-36.7%
30,2640.0%0.00%
Q2 2022$30,000
-16.7%
30,2640.0%0.00%
Q1 2022$36,000
-20.0%
30,2640.0%0.00%
Q4 2021$45,000
-8.2%
30,2640.0%0.00%
Q3 2021$49,000
-5.8%
30,2640.0%0.00%
Q2 2021$52,000
-34.2%
30,2640.0%0.00%
Q1 2021$79,00030,2640.00%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q3 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 7,941,867$1,443,0371.26%
Omnia Family Wealth, LLC 782,372$142,1570.11%
NEA Management Company, LLC 452,167$82,1590.01%
Hikari Power Ltd 130,821$240.00%
Bryn Mawr Capital Management, LLC 100,000$18,1700.00%
GEODE CAPITAL MANAGEMENT, LLC 30,264$5,4950.00%
MILLENNIUM MANAGEMENT LLC 261,192$470.00%
Renaissance Technologies 283,550$520.00%
LPL Financial LLC 134,453$24,4300.00%
JPMORGAN CHASE & CO 237$00.00%
View complete list of AKARI THERAPEUTICS PLC shareholders